The Week

Credo Tech (CRDO) fell 26.72% this week to close at $170.57, sharply underperforming the S&P 500, which rose 0.09%. The stock ran more than 26 percentage points behind the benchmark. It was a one-way sell-off: on Monday shares opened at $232.00, touched $238.395 intraday, and closed at $226.19. Tuesday dropped to $206.63. Wednesday accelerated after earnings, with volume surging to 30.1m shares and the price hitting an intraday low of $161.95 before closing at $165.22. Thursday slid further to $164.17, and Friday opened at $162.10 before rebounding to $170.57. Weekly amplitude was 33.47%, and average daily volume of 13.7m shares ran about 109% above its 60-day median, pointing to heavy distribution.

Key Events

The week’s main story was Credo’s fiscal Q1 2027 earnings and a negative reaction to its optical guidance. On Wednesday 2 September, the company reported record quarterly revenue of $479m, more than doubling year on year, and raised its overall Q2 outlook. Yet investors focused on optical products revenue forecast coming in below expectations, and valuation concerns took over. The stock fell more than 10% after hours and repeatedly printed declines of over 17% during the regular session. On Thursday the sell-off extended to more than 20%, with some put options up over 500% on the day. Quinn Bolton reiterated a buy rating with a $275 target, citing strengthening optical and AEC growth; JPMorgan lowered its expectations for the stock. A Form S-8 filed on 3 September was routine equity incentive paperwork, not a business development.

Analyst Ratings

Coverage stands at 19 firms: 14 rate it buy, 4 rate it overweight, and 1 is neutral; no firm carries underweight or sell. The consensus recommendation is strong buy, with a consensus target of $281.39, roughly 64.97% above the latest close of $170.57. Targets range from $185 to $350, a wide spread that reflects differing views on how fast the optical business can scale. Within the semiconductor manufacturers space, Credo’s rating rank is 20 out of 77, putting it in the upper-middle tier with coverage breadth close to the industry average.

The Week Ahead

The macro calendar is busier than the company-specific one. On Thursday 10 September, US initial jobless claims, producer price data, and the 10-year Treasury auction will land. Any shift in rate expectations or risk appetite could feed into high-valuation chip names that are already volatile. There is no scheduled earnings or company announcement for Credo next week, so the main watch item is whether the optical guidance reset from this week gets further digested or fades.

In Short

The weekly drop sits inside a tension between a strong headline quarter and weak optical guidance: revenue more than doubled and overall guidance was raised, but the optical forecast knocked the stock’s valuation premium lower. Broker ratings remain tilted positive, with the consensus target more than 60% above spot, yet the wide target range and mid-tier industry rank show the debate is not settled. The latest session’s flow data points to large-lot net selling while small-lot orders lean net buying, a structure that suggests institutional exit and retail absorption. The follow-through to watch is whether optical growth expectations get confirmed, and whether macro rate moves amplify volatility in a name already priced for steep AI-linked growth.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.